632|10000|Public
25|$|The European Forum for <b>Good</b> <b>Clinical</b> <b>Practice</b> (EFGCP) {{suggests}} that REBs include two practicing physicians who share experience in biomedical {{research and are}} independent from the institution where the research is conducted; one lay person; one lawyer; and one paramedical professional, e.g. nurse or pharmacist. They recommend that a quorum include both sexes from a wide age range and reflect the cultural make-up of the local community.|$|E
5000|$|<b>Good</b> <b>Clinical</b> <b>Practice</b> for Investigators, ROSTRUM Publications (July 1990) ...|$|E
5000|$|... #Subtitle level 2: Pharmaceutical {{trials and}} <b>good</b> <b>clinical</b> <b>practice</b> ...|$|E
30|$|This {{study was}} {{conducted}} in compliance with <b>good</b> <b>clinical</b> <b>practices</b> and the Declaration of Helsinki principles.|$|R
30|$|This propective single-center {{study was}} {{approved}} by the local Research Ethics Committee according to <b>good</b> <b>clinical</b> <b>practices</b> and applicable laws.|$|R
40|$|Intestinal intussusceptions are {{the most}} {{frequent}} cause of acute surgical occlusive syndrome in infants; it is idiopathic in more than 90 % of cases. Their treatment can be conservative, with reduction by means of imaging and hydrostatic procedures, or surgical. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Intestinal intussusceptions, approved by consensus in the 3 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Camagüey, Cuba; February 23 – 26, 2004). </strong...|$|R
50|$|The <b>Good</b> <b>Clinical</b> <b>Practice</b> Directive (Directive 2005/28/EC of 8 April 2005 of the European Parliament {{and of the}} Council) {{lays down}} {{principles}} and detailed guidelines for <b>good</b> <b>clinical</b> <b>practice</b> as regards conducting clinical trials of medicinal products for human use, {{as well as the}} requirements for authorisation of the manufacturing or importation of such products.|$|E
5000|$|To {{encourage}} and share <b>good</b> <b>clinical</b> <b>practice</b> and {{high standards of}} care ...|$|E
5000|$|Directive 2005/28/EC, defines <b>Good</b> <b>Clinical</b> <b>Practice</b> {{for design}} and conduct of {{clinical}} trials ...|$|E
40|$|Esophageal {{replacements}} {{in children}} usually are necessary {{in patients with}} of esophageal atresia or those develop inflammatory scars after consumption of caustic substances. For the substitutive procedure diverse organs are employed, like small or thick intestine and stomach. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Esophageal replacement, approved by consensus in the the 3 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Camagüey, Cuba; February 23 - 26, 2004). </strong...|$|R
30|$|Both studies {{required}} written informed consent, {{adherence to}} <b>Good</b> <b>Clinical</b> <b>Practices</b> and local regulations, and {{approval of the}} protocol by institutional review boards/ethics committees.|$|R
5000|$|<b>Good</b> <b>clinical</b> <b>practices</b> {{principles}} {{have been}} defined by Madelene Ottosen, RN, MSN, of The University of Texas Health Science Center at Houston [...] as: ...|$|R
5000|$|<b>Good</b> <b>clinical</b> <b>practice</b> for the design, conduct, {{recording}} and reporting of clinical trials: ...|$|E
5000|$|ISO 14155 Clinical {{investigation}} of medical devices for human subjects -- <b>Good</b> <b>clinical</b> <b>practice</b> ...|$|E
5000|$|<b>Good</b> <b>clinical</b> <b>practice</b> (GCP), for {{hospitals}} and clinicians conducting clinical studies on new drugs in humans ...|$|E
40|$|Esophageal {{injuries}} {{caused by}} the ingestion of corrosive substances (caustic) constitute {{one of the more}} dramatics affections in childhood and a challenge for pediatric surgeons. Frequently they leave esophageal strictures hard to treat, that many times require prolonged stricture dilatation and/or replacement of the esophagus. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Caustic ingestion in children, approved by consensus in the 2 nd National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Manzanillo, Cuba, September 31 - October 3, 2002). </strong...|$|R
40|$|As our modern-day {{understanding}} {{about the role of}} the spleen in the immune system has developed, indications for splenectomies have also changed. Illnesses like idiopatic thrombocytopenic purple, hereditary spherocytosis, sickle cell anemia, beta thalassemia, portal hypertension and other non-traumatic disseases that carry out with congestive splenomegaly and hypersplenism, find an effective alternative with the total or partially splenectomy. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Portal hypertension, approved by consensus in the 4 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Las Tunas, Cuba, March, 2005). </strong...|$|R
40|$|Biliary atresia is an obstructive and {{progressive}} process of unknown etiology that affects intra and/or extrahepatics biliary tracts and cause neonatal jaundice by serious obstruction of the biliary flow. It is {{presented with a}} frequency of 1 by each 10 000 – 15000 born alive. Is not hereditary and the most probable etiology is the progressive inflammatory illness of the biliary tracts. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Biliary atresia, approved by consensus in the 4 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Las Tunas, Cuba, March, 2005). </strong...|$|R
5000|$|... === <b>Good</b> <b>Clinical</b> <b>Practice</b> === The <b>good</b> <b>clinical</b> <b>practice</b> (GCP) [...] is an {{international}} ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. It was issued by ICH under <b>Good</b> <b>Clinical</b> <b>Practice</b> Directive (Directive 2005/28/EC) of 8 April 2005. A similar guideline for clinical trials of medical devices is the international standard ISO 14155, that is valid in the European Union as a harmonized standard.Compliance with the GCP standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the principles that {{have their origin in}} the Declaration of Helsinki, and that the clinical trial data are credible.|$|E
5000|$|Inspection and {{conformity}} assessment of <b>Good</b> <b>Clinical</b> <b>Practice</b> (GCP), Good Laboratory Practice (GLP), and Good Practice Systems and Programs (GPSP) ...|$|E
5000|$|In some US locations, {{the local}} IRB must certify {{researchers}} and their staff {{before they can}} conduct clinical trials. They must understand the federal patient privacy (HIPAA) law and <b>good</b> <b>clinical</b> <b>practice.</b> The International Conference of Harmonisation Guidelines for <b>Good</b> <b>Clinical</b> <b>Practice</b> {{is a set of}} standards used internationally for the conduct of clinical trials. The guidelines aim to ensure the [...] "rights, safety and well being of trial subjects are protected".|$|E
40|$|Anorectal malformations {{are one of}} big {{causes of}} de {{intestinal}} obstruction in newborns. They constitute around 25 % of digestive malformations. Have a frequency of 1 in 4000 born alive. They are more frequent in the male (1. 4 : 1) and 40 to 70 % of the patients have one or more associate anomalies. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Anorectal malformations, approved by consensus in the 2 nd National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Manzanillo, Cuba, September 31 - October 3, 2002). </strong...|$|R
40|$|Esophageal atresia is the {{congenital}} lack {{of continuity}} of the esophagus with or without communication to the airway. Incidence is estimateed in 1 by 3000 to 4500 alive newborns. Cases in brothers are found and children of parents with atresia esophagus, nevertheless not a hereditary is recognized; also {{there is a greater}} frequency in twins. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Esophageal atresia, approved by consensus in the 2 nd National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Manzanillo, Cuba, September 31 - October 3, 2002). </strong...|$|R
40|$|The {{pancreatic}} pseudocyst {{is the most}} common cystic lesion of the pancreas. It constitutes an amilasa rich liquid collection, located inside or adjacent to the pancreas; surrounded by a wall without ephithelium, as result of a sharp or chronic pancreatitis, pancreatic trauma, or obstruction of pancreatic conduit. 50 % solves spontaneously in 6 weeks, but some of they require surgical treatment. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Pancreatic pseudocysts, approved by consent in the 3 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Camagüey, Cuba; February 23 – 26, 2004). </span...|$|R
5000|$|... a final {{rule was}} issued on April 28, 2008 {{replacing}} the Declaration of Helsinki with <b>Good</b> <b>Clinical</b> <b>Practice</b> effective October 2008.|$|E
50|$|A Clinical Research Coordinator (CRC) is {{a person}} {{responsible}} for conducting clinical trials using <b>good</b> <b>clinical</b> <b>practice</b> (GCP) {{under the auspices of}} a Principal Investigator (PI).|$|E
50|$|A CRA {{is usually}} {{required}} to possess an academic degree in Life Sciences {{and needs to}} have a good knowledge of <b>good</b> <b>clinical</b> <b>practice</b> and local regulations.|$|E
40|$|The {{peritonitis}} is {{a general}} or localized inflammatory process of peritoneal membrane caused by chemical irritation, bacterial invasion, local necrosis or direct injuries of peritoneum. It is frequent cause of morbility in surgical patient and complication of many abdominals surgical interventions. It causes increased hospital demurrages, increased cost of medical attention and serious inconveniences to the patients and their familiies. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Peritonitis, approved by consensus in the 3 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Camagüey, Cuba; February 23 – 26, 2004...|$|R
50|$|Good {{manufacturing}} practices, {{along with}} good agricultural practices, good laboratory <b>practices</b> and <b>good</b> <b>clinical</b> <b>practices,</b> are overseen by regulatory {{agencies in the}} United States, Canada, Europe, China, and other countries.|$|R
40|$|Blunt {{abdominal}} trauma constitutes 90 % approximately of {{the abdominal}} injuries in children. Due to the augmented {{size of the}} child trunk {{in relation to their}} extremities, the abdominal lesions are extremely frequents. The abdominal trauma is present in 20 - 30 % of the patients with serious trauma. It's the second cause of death for accidents after the cranial traumatism in the pediatric patient. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Blunt Abdominal Trauma, approved by consensus in the 2 nd National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Manzanillo, Cuba, September 31 - October 3, 2002). </span...|$|R
50|$|Good {{operating}} practice is a strategic management term. More specific {{uses of the}} term include good agricultural practices, good manufacturing practice, good laboratory practice, <b>good</b> <b>clinical</b> <b>practice</b> and good distribution practice.|$|E
5000|$|Stevens W. (2003) Good Clinical Laboratory Practice (GCLP): The {{need for}} a hybrid of Good Laboratory Practice and <b>Good</b> <b>Clinical</b> <b>Practice</b> guidelines/standards for medical testing {{laboratories}} conducting clinical trials in developing countries. Quality Assurance, 10: 83-89.|$|E
5000|$|As {{part of its}} {{guidance}} on <b>Good</b> <b>Clinical</b> <b>Practice</b> (GCP), the International Conference on Harmonisation (ICH) has prepared a detailed guidance for {{the contents of the}} IB in the European Union (EU), Japan, and the United States (US).http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073122.pdf ...|$|E
40|$|Empyema is {{accumulation}} of puss in the cavity pleural, that can occupy part {{or all of}} it. The inflammatory fluid and the fibrin inside the pleural space {{is the result of}} an infection inside the pleural cavity that changes of watery liquid to suppurative collection inside the same one. Majority of parapneumonics discharges resolve without complications and with little clinical meaning, but some of they becomes empiema. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Pleural empyema, approved by consensus in the 4 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Las Tunas, Cuba, March, 2005). </strong...|$|R
40|$|Usually {{gastrointestinal}} bleeding doesn't have serious consequences in children, although the newborns and infants {{are more vulnerable}} to it. It can appear to any age, with more incidence of acute lesions of gastric and duodenal mucous in bleeding of upper gastrointestinal tract, and fissures and polyps in lower gastrointestinal tract causes. The most serious bleedings are secondary to esophageal varices and Meckel's diverticulum. A <b>good</b> <b>clinical</b> trial, supported by image and endoscopic tests, and standardized therapy, are the key elements for the reduction of mortality in these patients. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Gastrointestinal bleeding, approved by consensus in the the 4 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Las Tunas, Cuba; March 2005...|$|R
40|$|It is {{considered}} that every newborn that presents a confused aspect of external genitalia, {{that does not}} permit to define his phenotypic sex, has Ambiguous Genitals. It includes real cases of intersex abnormalities, or those with severe hypospadia and bilateral chryptorchidism. In spite of the large advances in genetic, hormonal regulation and molecular biology studies in intersex abnormalities, today continues being motive of confussion when a doctor found a newborn with ambiguous genitalia. We presented the <b>Good</b> <b>Clinical</b> <b>Practices</b> Guideline for Intersex and ambiguos genitalia, approved by consensus in the 4 th National <b>Good</b> <b>Clinical</b> <b>Practices</b> Workshop in Pediatric Surgery (Las Tunas, Cuba, March, 2005). </strong...|$|R
